UNIGE document Scientific Article
previous document  unige:48455  next document
add to browser collection
Title

The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation

Authors
Rezgui, M
Diaz, PH
Rousseau, J
Duval, M
Bittencourt, H
show hidden authors show all authors [1 - 10]
Published in The Pharmacogenomics Journal. 2014, vol. 14, no. 3, p. 263-71
Abstract Cytochrome P450 enzymes (CYPs) and flavin-containing monooxygenases (FMOs) likely have a role in the oxidation of intermediate metabolites of busulfan (Bu). In vitro studies to investigate the involvement of these enzymes are cumbersome because of the volatile nature of the intermediate metabolite tetrahydrothiophene (THT) and the lack of sensitive quantitation methods. This study explored the association between the CYP2C9, CYP2C19, CYP2B6 and FMO3 genotypes and sulfolane (Su, a water soluble metabolite of Bu) plasma levels in children undergoing hematopoietic stem cell transplantation (HSCT). The relationship between these genotypes and the effectiveness of myeloablative conditioning was also analyzed. Sixty-six children receiving an intravenous Bu-based myeloablative conditioning regimen were genotyped for common functional variant alleles in CYP2C9 (*2 and *3), CYP2C19 (*2 and *17), FMO3 (rs2266780, rs2266782 and rs1736557) and CYP2B6 (*5 and *9). The plasma levels of Bu and its metabolite Su were measured after the ninth Bu dose in a subset of 44 patients for whom plasma samples were available. The ratio of Bu to Su was considered the metabolic ratio (MR) and was compared across the genotype groups. Higher MRs were observed in CYP2C9*2 and *3 allele carriers (mean±s.d.: 7.8±3.6 in carriers vs 4.4±2.2 in non-carriers; P=0.003). An increased incidence of graft failure was observed among patients with an MR>5 compared with those with MR values <5 (20% vs 0%; P=0.02). In contrast, a significantly higher incidence of relapse and graft failure (evaluated as event-free survival) was observed in patients with malignant disease who carried CYP2B6 alleles with reduced function on both chromosomes compared with carriers of at least one normal allele (100% vs 40%; P=0.0001). These results suggest that CYP2C9 has a role in the oxidation reactions of THT and indicate that it may be possible to predict the efficacy of Bu-based myeloablative conditioning before HSCT on the basis of CYP genotypes and Bu MRs.
Keywords AdolescentAntineoplastic Agents, Alkylating/therapeutic useBusulfan/therapeutic useChildChild, PreschoolCytochrome P-450 Enzyme System/geneticsFemaleHematopoietic Stem Cell TransplantationHumansInfantInfant, NewbornMalePolymorphism, GeneticThiophenes/metabolismTransplantation Conditioning
Identifiers
PMID: 24165757
Full text
Article (Published version) (810 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research groups Plateforme d'oncologie et d'hématologie pédiatrique (907)
Groupe Desmeules Jules (pharmacologie/toxicologie) (567)
Citation
(ISO format)
UPPUGUNDURI SATYANARAYANA, Chakradhara Rao et al. The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation. In: The Pharmacogenomics Journal, 2014, vol. 14, n° 3, p. 263-71. https://archive-ouverte.unige.ch/unige:48455

166 hits

2 downloads

Update

Deposited on : 2015-03-26

Export document
Format :
Citation style :